The global immunomodulator therapeutics market is set to accelerate rapidly, surpassing $60 billion by 2030. In this episode of Frost & Sullivan’s Growth Podcast, we explore how innovation in precision immunology is transforming treatment for autoimmune diseases, cancers, and inflammatory disorders. Discover the impact of biosimilar competition, breakthrough small-molecule and bispecific antibody therapies, and mechanism-based R&D targeting immune pathways like TYK2 and FcRn. Learn where growth opportunities lie—from women’s health to transplant therapies—and the challenges of regulation, side effects, and access. Tune in to understand how strategic agility will define the future of immunology and how companies can thrive by mastering immune system control.

For more information, write to [email protected].